Serum cystatin C predicts mortality with cirrhotic ascites

Serum cystatin C predicts mortality with cirrhotic ascites
(HealthDay)—Serum cystatin C level is an excellent predictor of mortality in patients with cirrhotic ascites, according to a study published online Sept. 14 in the Journal of Gastroenterology and Hepatology.

Yeon Seok Seo, M.D., Ph.D., from the Korea University College of Medicine in Seoul, South Korea, and colleagues prospectively enrolled 350 patients with cirrhotic ascites (mean age, 55.4 years; 76.3 percent male) from 15 hospitals (September 2009 through March 2013). The authors sought to evaluate the prognostic efficacy of cystatin C level in patients with cirrhotic ascites.

The researchers found that serum creatinine and cystatin C levels were 0.9 and 1.1 mg/L, respectively. International normalized ratio (INR) and , sodium, and cystatin C levels were independent predictors of mortality, in multivariate analyses, while INR and and cystatin C levels were independent predictors of the development of type 1 hepatorenal syndrome (HRS-1). There was not a significant association noted between serum creatinine level and mortality or development of HRS-1.

"Predictive models based on serum cystatin C level instead of would be more helpful in the assessment of the condition and prognosis of patients with cirrhotic ascites," the authors write.


Explore further

New, combined equation more accurately estimates GFR

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Serum cystatin C predicts mortality with cirrhotic ascites (2017, September 23) retrieved 21 May 2019 from https://medicalxpress.com/news/2017-09-serum-cystatin-mortality-cirrhotic-ascites.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more